FEV1 is not sufficient for assessing bronchodilator reversibility in chronic obstructive pulmonary disease

A. S. Rubin, F. M. B. Tavares, L. C. Correa da Silva (Porto Alegre, Brazil)

Source: Annual Congress 2004 - COPD: insights from structure and function
Session: COPD: insights from structure and function
Session type: Thematic Poster Session
Number: 828
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. S. Rubin, F. M. B. Tavares, L. C. Correa da Silva (Porto Alegre, Brazil). FEV1 is not sufficient for assessing bronchodilator reversibility in chronic obstructive pulmonary disease. Eur Respir J 2004; 24: Suppl. 48, 828

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Evaluation of bronchodilator responses in chronic obstructive pulmonary disease patients
Source: Eur Respir J 2002; 20: Suppl. 38, 247s
Year: 2002

Bronchodilator responsiveness in patients with COPD
Source: Eur Respir J 2008; 31: 742-750
Year: 2008



Post-bronchodilator FVC determines pulmonary rehabilitation outcomes in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2011 - Challenges in rehabilitation: some old dilemmas revisited with some solutions?
Year: 2011

The effect of oral corticosteroids on spirometric parameters in chronic obstructive pulmonary disease
Source: Annual Congress 2008 - Advances in the treatment and pathogenesis of pulmonary diseases
Year: 2008

A comparison of airways resistance and spirometry in patients with acute exacerbations of chronic obstructive pulmonary disease
Source: Annual Congress 2010 - COPD: treatment and monitoring
Year: 2010

Pharmacodynamic steady state of tiotropium in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2002; 19: 639-644
Year: 2002



The effect of pulmonary rehabilitation toward expiratory airflow limitation in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2011 - Challenges in rehabilitation: some old dilemmas revisited with some solutions?
Year: 2011

Assessment of inhalation technique in patients with bronchial asthma and chronic obstructive pulmonary disease
Source: Virtual Congress 2020 – Asthma inhalers: devices and adherence studies
Year: 2020


Effect of salmeterol on the ventilatory response to exercise in chronic obstructive pulmonary disease
Source: Eur Respir J 2004; 24: 86-94
Year: 2004



Ventilatory and perfusion defects in chronic obstructive pulmonary disease (COPD) and response to bronchodilators
Source: Annual Congress 2007 - Imaging of pulmonary vascularisation and illustrated overview of lung pathology
Year: 2007


A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease
Source: Eur Respir J 2002; 19: 217-224
Year: 2002



Asthma versus chronic obstructive pulmonary disease
Source: ISSN=1025-448x, ISBN=1-904097-26-x, page=195
Year: 2003

Evaluation of bronchodilator responses in patients with "irreversible" emphysema
Source: Eur Respir J 2001; 18: 914-920
Year: 2001



Effects of long-acting bronchodilators on changes of inspiratory capacity by hyperventilation in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2006; 28: Suppl. 50, 430s
Year: 2006

Reversibility of airflow limitation in patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2004; 24: Suppl. 48, 587s
Year: 2004

Influence of bronchodilators on pulmonary hypertension in patients with chronic obstructive pulmonary disease (COPD) and COPD concomitant with bronchial asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 521s
Year: 2004

Characteristics of airway hyperresponsiveness and reversibility in asthma and chronic obstructive pulmonary disease
Source: Annual Congress 2008 - PG17 - An expert view of the differences between asthma and COPD
Year: 2008


Bronchodilator-induced changes in dynamic hyperinflation but not in airway obstruction are associated with improvement in dyspnoea in patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2001; 18: Suppl. 33, 174s
Year: 2001

Acute reversibility of airflow limitation and sputum eosinophilia in chronic obstructive pulmonary disease
Source: Eur Respir J 2004; 24: Suppl. 48, 579s
Year: 2004

Forced inspiratory volume in one second (FIV1) in the assessment of reversibility of airway obstruction in patients with chronic obstructive pulmonary disease (COPD) and in relation to the severity
Source: Eur Respir J 2002; 20: Suppl. 38, 300s
Year: 2002